PharmaNet Development Group’s subsidiary, PharmaNet Canada, Inc., and The Research Institute of McGill University Health Centre (RI MUHC) have signed a Letter of Intent to jointly form, manage, and operate the first in-hospital translational medicine unit for Phase I–IIa studies in Canada. The facility will be located at the Montreal General Hospital and is expected to begin operations in 2012. “We are thrilled to announce this joint venture with RI MUHC, a world-renowned research facility,” sa...